New drug duo targets Tough-to-Treat leukemia
NCT ID NCT01869114
Summary
This study tested whether combining two drugs, sirolimus and azacitidine, could help control high-risk myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) in adults. The trial enrolled 57 patients whose cancer had returned or who could not tolerate standard high-dose chemotherapy. Researchers aimed to see if the combination was safe and more effective at stopping cancer growth than previous treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ADULT ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abington Hospital - Jefferson Health
Abington, Pennsylvania, 19001, United States
-
Jefferson Health NJ Division (Kennedy Hospital)
Sewell, New Jersey, 08012, United States
-
Jefferson Health, Aria Hospital
Philadelphia, Pennsylvania, 19124, United States
-
Jefferson Health, Methodist Hospital
Philadelphia, Pennsylvania, 19148, United States
-
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.